Pharma Rep Focus

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

tag aduhelm

What is Biogen and can they repair their reputation?

World of DTC Marketing

SEPTEMBER 24, 2021

This week two colleagues, who worked at Biogen, left the company because they knew that the ax was coming after the failure of Aduhelm. More importantly, they felt the company should never have launched Aduhelm. Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place.

Insurance

Insurance Pharma Doctors Physicians

The FDA and Aduhelm: WTF?

World of DTC Marketing

JUNE 23, 2021

SKIMMERS SUMMARY: Jefferies analysts found doctors have shown strong interest in prescribing Aduhelm for about 35% of early-stage Alzheimer’s patients with mild cognitive impairment after surveying 50 U.S. Biogen’s Aduhelm won FDA approval after discovering that some patients on higher dosages had displayed improvement of.39

FDA

FDA Side effects Physicians Patients

What is Biogen and can they repair their reputation?

The FDA and Aduhelm: WTF?

Stay Connected